从试验创新网络的初始咨询过程中的见解
Paul A Harris1,2, Nan Kennedy1, Consuelo H Wilkins1,3,4
1Vanderbilt Institute for Clinical and Translational Research, Nashville, TN, USA.
Journal of clinical and translational science
|July 30, 2025
概括
试验创新网络 (TIN) 提供免费的专家咨询,以提高多中心临床试验设计和效率. 该网络通过为研究人员提供量身定制的支持和标准化的流程来加速研究.
科学领域:
- 临床和翻译科学 临床和翻译科学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多中心临床试验在设计,协调,招聘和合规方面面临挑战.
- 为了解决这些问题,美国国立卫生研究院的国家推进翻译科学中心建立了试验创新网络 (TIN).
研究的目的:
- 描述试验创新网络的科学咨询过程.
- 评估TIN咨询对多中心临床试验质量和效率的影响.
- 为其他试验支持网络分享经验教训.
主要方法:
- TIN提供了与专家进行科学商的过程,对调查人员来说无需任何费用.
- 初始商过程评估研究前提,设计,现场开发,招聘和资金.
- 该TIN利用来自临床和翻译科学奖项 (CTSA) 计划的资源.
主要成果:
- 截至2024年6月1日,TIN已经提供了431次初步商.
- TIN已经为多中心试验开发了标准化,简化和可适应的流程.
- 通过量身定制的建议,TIN咨询旨在提高效率并加快试验实施.
结论:
- 试验创新网络通过专家咨询和资源利用来提高多中心试验的质量和效率.
- 由TIN开发的标准化和可适应的流程可以使其他试验支持网络受益.
- TIN的方法促进跨学科的团队合作,并促进临床试验的创新.
更多相关视频
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.4K
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
12.0K
相关概念视频
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Nursing Clinical Information System
867
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
867
Trial and Error and Algorithm
193
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
193
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
